MYRIAD GENETICS Stock Quote

$36.79 arrow  Change: 0.93 %Chge: 2.59% Vol: 40,999
End Of Day Prices
High: 36.91 | Low: 36 | Open: 36 | Close: 36.79
52 Wk High: 37.2 | 52 Wk Low: 15.16 | Todays Pivot: 36.57
Sector: Healthcare and Pharmaceuticals add stock to watch list

MYGN Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Davita 69.15 red arrow 85,167
Mednax 65.75 green arrow 16,956
United Therapeutics Del 123.49 red arrow 26,698
Dentsply Intl 52.14 red arrow 49,300
Express Scripts 82.7 red arrow 527,250
United Therapeutics Del 100.22 green arrow 59,438
Sirona Dental Systems 73.5 red arrow 17,110
Edwards Lifesciences 71.95 green arrow 63,481

Above is a small selection of related companies to Myriad Genetics which compete alongside MYGN within the Healthcare and Pharmaceuticals sector. To see more related companies to MYGN, view our stock market today information page.

Online News For Myriad Genetics

Myriad Genetics Inc. (MYGN) Moves Higher on Volume Spike for January 17

Myriad Genetics Inc. (MYGN) traded on unusually high volume on Jan. 17, as the stock gained 2.93% to close at $36.84. On the day, Myriad Genetics Inc. saw 1.04 million shares trade hands on 7,452 trades. Considering that the stock averages only a daily ...


Myriad Genetics, Inc. (MYGN) Holdings Decreased by Cornerstone Capital Management Holdings LLC.

Cornerstone Capital Management Holdings LLC. reduced its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN) by 13.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC).


Myriad Genetics (MYGN) Presents Positive riskScore Test Data

Myriad Genetics, Inc. MYGN presented encouraging data from a study to evaluate the risk of breast cancer in women of European lineage with a negative myRisk Hereditary Cancer test result for a hereditary cancer mutation. Notably, the results were presented ...


Contrarius Investment Management LTD Has Trimmed By $925,776 Its Myriad Genetics (MYGN) Position; Brinker Capital Has Cut Its Hasbro (HAS) Holding

Contrarius Investment Management Ltd decreased Myriad Genetics Inc (MYGN) stake by 7.7% reported in 2017Q3 SEC filing. Contrarius Investment Management Ltd sold 25,716 shares as Myriad Genetics Inc (MYGN)’s stock rose 13.21%. The Contrarius Investment ...


Can EPD & Medical Devices Drive Abbott's (ABT) Q4 Earnings?

You can see the complete list of today's Zacks #1 Rank stocks here. Myriad Genetics, Inc. MYGN has an Earnings ESP of +0.42% and a Zacks Rank #3. Henry Schein, Inc. HSIC has an Earnings ESP of +0.35% and a Zacks Rank #3. Zacks Top 10 Stocks for 2018 In ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Myriad Genetics quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for MYGN to choose from. Visit here to build your stock quote widget »